Condition: Prostate Cancer · Sponsor: Copenhagen University Hospital at Herlev
HIP is a randomized controlled trial. The aim is investigate the effect, safety and feasibility of brief, high-impact exercise targeting bones in patients with prostate cancer and bone metastases. Furthermore, to investigate the effects of the intervention on bone status (bone mineral density) and body composition, physical function and performance, patient reported quality-of-life outcomes, falls and hospitalizations. The effects of resistance training on the antitumor immunity will be assessed in the peripheral blood and tumor biopsies (HIPimmune).
This description comes directly from the study's public registry record.
Anne-Mette Ragle, PhD student · +4527128044 · anne-mette.ragle@regionh.dk
Peter Busch Østergren, MD, PhD · peter.busch.oestergren@regionh.dk
Always discuss trial participation with your own doctor first.
| Herlev and Gentofte Hospital | Herlev, Herlev, Denmark | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06259279